Skip to Content

APRESAZIDE 25/25 CIBA 139 (Apresazide 25 mg / 25 mg)

Generic Name: hydralazine/hydrochlorothiazide

Pill with imprint APRESAZIDE 25/25 CIBA 139 is Blue / White, Capsule-shape and has been identified as Apresazide 25 mg / 25 mg. It is supplied by Novartis Pharmaceuticals.

Apresazide is used in the treatment of high blood pressure; heart failure and belongs to the drug class miscellaneous antihypertensive combinations. Risk cannot be ruled out during pregnancy. Apresazide 25 mg / 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APRESAZIDE 25/25 CIBA 139

Apresazide

Generic Name:
hydralazine/hydrochlorothiazide
Imprint:
APRESAZIDE 25/25 CIBA 139
Strength:
25 mg / 25 mg
Color:
Blue / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antihypertensive combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
National Drug Code (NDC):
00083-0139

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide